Study of the Antihypertensive and Vasorelaxant Activities of Haloxylon scoparium in Rats
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
AIMS: The work aimed to study the antihypertensive ability of Haloxylon scoparium.
BACKGROUND: Haloxylon scoparium Pomel is used to treat various diseases, including hypertension.
OBJECTIVE: This study aimed to evaluate the antihypertensive effect of Haloxylon scoparium (H. scoparium) in hypertensive rats, and to evaluate its probable vasorelaxant activity.
MATERIALS AND METHODS: The aqueous extract of Haloxylon scoparium (AEHS) was prepared and used to investigate its antihypertensive ability in L-NAME(Nω-L-arginine methyl ester)-induced hypertensive rats, and its vasorelaxant activity was studied on the isolated thoracic aorta of rats. The acute and subchronic effects of (AEHS) on blood pressure parameters were evaluated after oral administration of AEHS (60 and 100 mg/kg body weight) for 6 h for the acute experiment and for 7 days for the subchronic test.
RESULTS: The results indicated that AEHS decreased blood pressure parameters (systolic, mean, and diastolic blood pressure) after repeated oral administration in hypertensive rats without affecting normal rats. In addition, AEHS (375-1250 μg/mL) revealed a vasorelaxant effect in thoracic aortic rings precontracted with norepinephrine (NE) (10 μM) or KCl (80 mM). This effect was partially decreased in the presence of nifedipine by inhibition of the vascular calcium channel pathway in isolated rat thoracic aorta.
CONCLUSION: The study demonstrates the beneficial effect of Haloxylon scoparium as an antihypertensive agent. Moreover, this plant exerts vasorelaxant activity via the blockade of Ca2+ channels.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Cardiovascular & hematological agents in medicinal chemistry - 21(2023), 2 vom: 23., Seite 139-153 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Amtaghri, Smail [VerfasserIn] |
---|
Links: |
---|
Themen: |
Angiotensin converting enzyme- 2(ACE2) |
---|
Anmerkungen: |
Date Completed 10.03.2023 Date Revised 10.03.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1871525720666220823163542 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345362268 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345362268 | ||
003 | DE-627 | ||
005 | 20231226024908.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1871525720666220823163542 |2 doi | |
028 | 5 | 2 | |a pubmed24n1151.xml |
035 | |a (DE-627)NLM345362268 | ||
035 | |a (NLM)36017835 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Amtaghri, Smail |e verfasserin |4 aut | |
245 | 1 | 0 | |a Study of the Antihypertensive and Vasorelaxant Activities of Haloxylon scoparium in Rats |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.03.2023 | ||
500 | |a Date Revised 10.03.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a AIMS: The work aimed to study the antihypertensive ability of Haloxylon scoparium | ||
520 | |a BACKGROUND: Haloxylon scoparium Pomel is used to treat various diseases, including hypertension | ||
520 | |a OBJECTIVE: This study aimed to evaluate the antihypertensive effect of Haloxylon scoparium (H. scoparium) in hypertensive rats, and to evaluate its probable vasorelaxant activity | ||
520 | |a MATERIALS AND METHODS: The aqueous extract of Haloxylon scoparium (AEHS) was prepared and used to investigate its antihypertensive ability in L-NAME(Nω-L-arginine methyl ester)-induced hypertensive rats, and its vasorelaxant activity was studied on the isolated thoracic aorta of rats. The acute and subchronic effects of (AEHS) on blood pressure parameters were evaluated after oral administration of AEHS (60 and 100 mg/kg body weight) for 6 h for the acute experiment and for 7 days for the subchronic test | ||
520 | |a RESULTS: The results indicated that AEHS decreased blood pressure parameters (systolic, mean, and diastolic blood pressure) after repeated oral administration in hypertensive rats without affecting normal rats. In addition, AEHS (375-1250 μg/mL) revealed a vasorelaxant effect in thoracic aortic rings precontracted with norepinephrine (NE) (10 μM) or KCl (80 mM). This effect was partially decreased in the presence of nifedipine by inhibition of the vascular calcium channel pathway in isolated rat thoracic aorta | ||
520 | |a CONCLUSION: The study demonstrates the beneficial effect of Haloxylon scoparium as an antihypertensive agent. Moreover, this plant exerts vasorelaxant activity via the blockade of Ca2+ channels | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Ca<sup>2+</sup> channels | |
650 | 4 | |a Haloxylon scoparium pomel | |
650 | 4 | |a L-NAME | |
650 | 4 | |a MLN-4760 | |
650 | 4 | |a angiotensin converting enzyme- 2(ACE2) | |
650 | 4 | |a hypertension | |
650 | 4 | |a vasorelaxant | |
650 | 7 | |a Vasodilator Agents |2 NLM | |
650 | 7 | |a Antihypertensive Agents |2 NLM | |
650 | 7 | |a Plant Extracts |2 NLM | |
700 | 1 | |a Eddouks, Mohamed |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cardiovascular & hematological agents in medicinal chemistry |d 2006 |g 21(2023), 2 vom: 23., Seite 139-153 |w (DE-627)NLM161201482 |x 1875-6182 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2023 |g number:2 |g day:23 |g pages:139-153 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1871525720666220823163542 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2023 |e 2 |b 23 |h 139-153 |